BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Thrombotargets Corporation Europe Inagurates New Facilities at the National Biotechnology Center in Madrid, Spain


4/23/2007 2:52:45 PM

Madrid, Spain - As part of the strategic collaborations between Thrombotargets Europe S.L.(www.thrombotargets.com) and Public Research Institutions, Thrombotargets Europe has reached an agreement with the CNB, belonging to the Spanish Research Council (CSIC), to have access to a research laboratory located at the new CNB-annex building designed for the purpose of starting-up biotech initiatives.

The new 2500 square feet laboratory will be operative on the second week of February 2007 and will envisage the future growth of the company for the next three years. CNB offers to Thrombotargets Europe research team a full access to the most advanced facilities, such as proteomic and genomic services, protein design, protein tools, electron microscopy, transgenesis and animal facilities (www.cnb.uam.es). In addition, this agreement will facilitate further interaction of Thrombotargets Europe members with the research activities of one of the most advanced biotech institutes in Europe.

The potential of this new research laboratory in cooperation with tha already existing facilities in Barcelona will provide Thrombotargets the capability to undertake research projects from drug discovery to clinical trials.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES